Cure8 research brief
If epithelial cells themselves retain disease-linked programs, that could help explain persistent intestinal abnormalities in Crohn’s disease even during remission and point to new biomarker or therapeutic targets focused on the epithelium or on metabolite–epithelial interactions.
Researchers studying IBD mechanisms, single-cell and organoid modelers, translational scientists exploring epithelial-targeted therapies or biomarkers, and clinicians interested in the biology underlying remission and relapse.
The study used donor-matched intestinal biopsies and derived epithelial-enriched organoids from patients with active and inactive Crohn’s disease and from controls, then applied single-cell RNA-seq and ATAC-seq to tissue and organoid cells.
Organoids from Crohn’s patients retained autonomous disease-associated epithelial states, while tissue signatures additionally reflected immune and microbial interactions. When exposed to luminal metabolites from patients, Crohn’s organoids showed selective activation of disease-related transcriptional programs and chromatin remodeling.
The work is preclinical and mechanistic: it aims to separate cell-intrinsic epithelial alterations from environmental influences (microbial/metabolite cues) using organoid models and single-cell genomics. The findings suggest both intrinsic epithelial dysregulation and microenvironmental signals contribute to persistent disease-associated states.
No clinical recommendations or treatment changes are reported; this is an early laboratory study that may guide future biomarker or therapeutic research.
This is a bioRxiv preprint (not peer reviewed) reporting mechanistic laboratory results using organoids, single-cell RNA-seq and ATAC-seq, and patient-derived luminal metabolites. Findings are preliminary and require independent validation and clinical correlation before they can inform patient care.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The findings suggest B cells and shared antibody responses may play a role in Crohn’s disease, which could point to new biomarkers or targets for future research. For patients, this helps explain why scientists are...
The finding links a specific mucus-associated protein (HMGB1) to barrier defects in Crohn’s disease, which could help explain how bacteria reach and inflame tissue in active lesions and point to future biomarker or...
The work models how Mycobacterium avium can provoke epithelial inflammation similar to Crohn's disease, pointing to possible molecular links between infection and CD-like pathology that could guide future research.
